Skip to content

Assessment of a New Surgical Smoke Clearing Technology in Laparoscopic Cholecystectomy

Assessment of a New Surgical Smoke Clearing Technology, Innervision, in Laparoscopic Cholecystectomy

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01534832
Acronym
Innervision
Enrollment
30
Registered
2012-02-17
Start date
2012-04-30
Completion date
2012-08-31
Last updated
2012-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Focus: Surgical Smoke During Laparoscopic Surgery

Keywords

surgical smoke, laparoscopic surgery, impaired vision

Brief summary

The study will examine the safety and performance of a new surgical smoke clearance system designed for use during laparoscopic surgery.

Detailed description

The study will examine the safety and performance of a new surgical smoke clearance system which has been developed to maintain a visually clear operative field during laparoscopic surgery by using electrostatic precipitation to clear, from the surgical field, smoke and plume produced by energy based surgical instruments e.g. electrocautery, laser tissue ablation and ultrasonic scalpel tissue dissection.

Interventions

DEVICEInnervision Surgical Smoke Removal System

Smoke removal by electrostatic precipitation

Sponsors

Asalus Medical Instruments Limited
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Male or female, at least 18 years of age 2. Undergoing elective laparoscopic cholecystectomy for documented symptomatic gallstone disease 3. Patient or authorised representative must be able to comprehend and sign the Informed Consent Form prior to enrolment in the study.

Exclusion criteria

1. \<18 years of age 2. Pregnant or lactating females 3. Previous extensive abdominal surgery, which in the opinion of the Investigator presents a \>5% risk of conversion to an open procedure being required 4. Current participation in another device or drug study 5. Unwilling or unable to provide informed consent

Design outcomes

Primary

MeasureTime frame
Maintenance of a clear visual field during surgery3m

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026